Skip Navigation
Skip to contents

ICKSH 2024

END 2026-06-06

Scientific Program

Filter
SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

[YI] Young Investigator Award Presentation

Room 1 (Vista Hall 1)
  • March 30 (Sat), 08:00-09:00
  • Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
    Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
  • Comparison Hyunkyung Park (University of Ulsan College of Medicine, Korea) Evaluation of plasma cell sorting methods in multiple myeloma patients: Flow cytometry versus magnetic beads Saeam Shin (Yonsei University College of Medicine, Korea) Comparative analysis of genes according to ropeginterferon alfa-2b treatment response in patients with polycy - themia vera Seug Yun Yoon (Soonchunhyang University College of Medicine, Korea) Single-cell transcriptome analysis to investigate the immune profile of T cells post-allogeneic hematopoietic stem cell transplantation and elucidate mechanisms underlying graft-versus-host disease Jong Hyuk Lee (College of Medicine, The Catholic University of Korea, Korea) Characterization of cytotoxic CD4 T cells to promote cellular immunotherapy outcome in multiple myeloma Hyunsoo Cho (Yonsei University College of Medicine, Korea) A study on the utility of next-generation sequencing-based assays for immunoglobulin gene rearrangement usage repertoire analysis and measu rable residual disease monitoring in B-cell acute lymphoblastic leukemia Daehyun Chu (University of Ulsan College of Medicine, Korea) Clinical impact of NGS-based measurable residual disease as prognostic marker in pediatric acute myeloid leukemia Hyun Jin Park (Seoul National University College of Medicine, Korea) Identification of relapse related clones using minimal residual disease monitoring by next-generation sequenc - ing in Korean pediatric patients with acute myeloid leukemia Jong-Mi Lee (College of Medicine, The Catholic University of Korea, Korea) The impact of the tumor immune microenvironment on the efficacy of CAR T-cell therapy or Bi-specific antibody therapy in relapsed or refractory diffuse large B-cell lymphoma Hyungwoo Cho (University of Ulsan College of Medicine, Korea)

[ES06] Education Session 06

Essential knowledge for optimal hematologic consultation (Kor)

Room 1 (Vista Hall 1)
  • March 30 (Sat), 09:00-10:15
  • Jong Ho Won (Soonchunhyang University College of Medicine, Korea)
    Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
  • Functional iron deficiency in cancer patients Ik-Chan Song (Chungnam National University College of Medicine, Korea) Assessment of neutropenia in hospitalized patients Young Hoon Park (Ewha Womans University College of Medicine, Korea) Perioperative consultation for the appropriate transfusion Ka-Won Kang (Korea University College of Medicine, Korea)

[SS14] Scientific Session 14

Novel insights into pathogenesis of MPN

Room 2 (Vista Hall 2)
  • March 30 (Sat), 09:00-10:15
  • Chul Won Choi (Korea University College of Mecine, Korea)
    Sung-Yong Kim (Konkuk University School of Medicine, Korea)
  • Myeloproliferative neoplasms and inflammation Steffen Koschmieder (RWTH Aachen University, Germany) Signaling contributing to the development of myelofibrosis: Beyond JAK/STAT Douglas Tremblay (Mount Sinai School of Medicine, USA) Clonal evolution in myelofibrosis Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea)

[SS15] Scientific Session 15

Immunotherapies for lymphomas non-benefited from CAR-T cell

Room 3 (Grand Hall 1)
  • March 30 (Sat), 09:00-10:15
  • Jae-Yong Kwak (Jeonbuk National University Medical School, Korea)
    Deok-Hwan Yang (Chonnam National University Medical School, Korea)
  • Treatment options for relapsed/refractory Hodgkin lymphoma after brentuximab vedotin and PD-1 blockade Alex F. Herrera (City of Hope, USA) Aggressive B-cell lymphomas: Immuno-chemotherapies other than CAR-T cell therapies Jason Westin (The University of Texas MD Anderson Cancer Center, USA) Extranodal NK/T cell lymphoma: The immunogenic tumor Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)

[ES07] Education Session 07

Basic genomics for clinical hematologists (Kor)

Room 4 (Art Hall)
  • March 30 (Sat), 09:00-10:15
  • Hee-Jin Kim (Sungkyunkwan University School of Medicine, Korea)
    In-Suk Kim (Pusan National University School of Medicine, Korea)
  • Genomic technologies for detecting structural variations in hematologic malignancies Miae Jang (Sungkyunkwan University School of Medicine, Korea) The role of NGS in hematologic malignancies Young-Uk Cho (University of Ulsan College of Medicine, Korea) Germline predisposition to hematologic malignancies Sang Mee Hwang (Seoul National University College of Medicine, Korea)

[PAP01] Plenary Abstract Presentation 01

Plenary Abstract Presentation

Room 1 (Vista Hall 1)
  • March 30 (Sat), 10:30-11:15
  • Dong Yeop Shin (Seoul National University College of Medicine, Korea)
    Yoon Seok Choi (Korea University College of Medicine, Korea)
  • A single-arm, open-label, multicenter study to assess molecular response of P1101 therapy in patients with polycythemia vera and elevated hematocrit: Results from 48 weeks core study Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea) Novel genomic variants influencing methotrexate delayed excretion in pediatric patients with acute lympho - blastic leukemia Jung Yoon Choi (Seoul National University College of Medicine, Korea) Prognostic utility of minimal residual disease (MRD) after curative intent induction therapy for DLBCL: A prospec - tive real-world ctdna study Sang Eun Yoon (Sungkyunkwan University School of Medicine, korea)

Go top

Go top

Hosted by
  • The Korea Society of Hematology
Supported by
  • 한국관광공사
  • 서울특별시

Sponsored by

ICKSH2024 Secretariat: People-X, Inc.
1F, Haeoreum B/D 16, Yeoksam-ro 17 gil, Yeoksam-dong, Gangnam-gu, Seoul 06246, Korea

Tel: +82-2-566-6031 (General Information) +82-2-566-5058 (Program & Abstract) |Fax: +82-2-566-6087| E-mail: icksh@icksh.org

President (대표자) : Seongsoo Jang (장성수)|Business license (사업자등록번호) : 205-82-63080